Published: 17 Apr 2024
3 min
3 min read
40

Biotech company uses microbial fermentation process in carbon recycling technology

CustomerLife science researchMicrobial bioprocess

Zara Summers, Chief Science Officer at LanzaTech, a Biotech Company, vividly articulates the company goal to reduce fossil fuel consumption and instead, recycle carbon, that is already above ground to create necessities: "We want it so every child in the world can pick up a crayon and color the sky and have that crayon that they pick be blue. Right? And today that is not the reality for every kid around the world."

Zara Summers, Chief Science Officer at LanzaTech, a Biotech Company, vividly articulates the company's goal to reduce fossil fuel consumption and instead, recycle carbon, that is already above ground to create necessities.

We are proud to have supplied the INFORS HT Multifors bioreactors and eve® bioprocess platform software featured in the recent ABC7 Chicago article about LanzaTech's groundbreaking carbon recycling technology. The article highlights LanzaTech's innovative approach to reducing carbon emissions by capturing them from industrial sources and converting them into valuable products through microbial fermentation processes.

The Multifors Bioreactor stands out as an industry-leading product with our customer because it withstands the long running cycles required for their processes without any interruptions. The Multifors has a reliable magnetic drive system, capable of high RPM agitation for months at a time during extended continuous batches. This allows LanzaTech to increase their R&D productivity while maximizing their lab space efficiently.

The eve® bioprocess platform software further optimizes their R&D fermentation operations, connecting dozens of bioreactor systems to a web browser-based software platform across multiple lab spaces. Controlling, monitoring, and analyzing your bioprocess has never been easier and more efficient.

Our bioreactors and software play a crucial role in LanzaTech’s R&D work by providing the ideal environment for microbial fermentation for testing, optimizing, and prototyping. LanzaTech is continuously improving and optimizing its commercial process for converting captured carbon emissions into raw materials to produce a variety of useful products, including packaging, apparel, and fuels.

By supporting LanzaTech’s efforts, we’re not only helping to combat climate change by reducing carbon emissions, but we’re also effecting the development of a circular economy where waste is transformed into valuable resources.

Watch the full news report

Learn more about the products mentioned in this article

Multifors 2 bench-top bioreactor

Manage multiple bioreactor vessels in parallel while mitigating risks during scale-up.

eve bioprocess software services

Dedicated assistance for seamless software performance with our eve support team.

Bioreactor services

Maintain optimal performance and longevity in your bioreactors with a range of services and support.

Multifors 2 bench-top bioreactor

Manage multiple bioreactor vessels in parallel while mitigating risks during scale-up.

eve bioprocess software services

Dedicated assistance for seamless software performance with our eve support team.

Bioreactor services

Maintain optimal performance and longevity in your bioreactors with a range of services and support.

Did you like this article?Leave us a rating!

1
2
3
4
5
Average: 4/5

Comments(0)

Related articles

Blog
23 Oct 20249 min read40
Optimizing HEK293 cell cultures for gene therapy applications: the role of incubator flexibility

Gene therapy is a promising approach for treating various genetic disorders and diseases. A critical component of gene therapy is the production of viral vectors, which serve as delivery vehicles for therapeutic genes. Human Embryonic Kidney 293 (HEK293) cells have become a widely used platform for viral vector production due to their efficiency in transfection and ability to support viral replication. However, optimizing HEK293 cell cultures for large-scale production of viral vectors remains a challenge in making gene therapies more accessible and cost-effective.

20 Sep 20244 min read50
Sustainable dairy innovation: Daisy Lab uses precision fermentation to produce animal-free milk proteins in INFORS HT bioreactors

As demand for sustainable food sources surges, Daisy Lab is revolutionizing dairy production with precision fermentation technology. By using INFORS HT bioreactors, this New Zealand-based startup is producing animal-free milk proteins like whey and casein. Discover how the innovative process at Daisy Labs, now set to scale with EPA approval, is paving the way for a more sustainable future in dairy.

24 Jun 20244 min read52
Transforming bioprocess research and development with INFORS HT bioreactor system design

Discover how INFORS HT’s bioreactor systems enhance bioprocess R&D for the Agro-Biotechnology Institute. Explore their streamlined operations and optimized yields. An interview-style article with Dr. Siti Rokhiyah PhD., Head of Bioreactor Unit at the Agro-Biotechnology Institute (ABI), National Institutes of Biotechnology Malaysia (NIBM) in Malaysia.

23 Oct 20249 min read40
Optimizing HEK293 cell cultures for gene therapy applications: the role of incubator flexibility

Gene therapy is a promising approach for treating various genetic disorders and diseases. A critical component of gene therapy is the production of viral vectors, which serve as delivery vehicles for therapeutic genes. Human Embryonic Kidney 293 (HEK293) cells have become a widely used platform for viral vector production due to their efficiency in transfection and ability to support viral replication. However, optimizing HEK293 cell cultures for large-scale production of viral vectors remains a challenge in making gene therapies more accessible and cost-effective.

20 Sep 20244 min read50
Sustainable dairy innovation: Daisy Lab uses precision fermentation to produce animal-free milk proteins in INFORS HT bioreactors

As demand for sustainable food sources surges, Daisy Lab is revolutionizing dairy production with precision fermentation technology. By using INFORS HT bioreactors, this New Zealand-based startup is producing animal-free milk proteins like whey and casein. Discover how the innovative process at Daisy Labs, now set to scale with EPA approval, is paving the way for a more sustainable future in dairy.

24 Jun 20244 min read52
Transforming bioprocess research and development with INFORS HT bioreactor system design

Discover how INFORS HT’s bioreactor systems enhance bioprocess R&D for the Agro-Biotechnology Institute. Explore their streamlined operations and optimized yields. An interview-style article with Dr. Siti Rokhiyah PhD., Head of Bioreactor Unit at the Agro-Biotechnology Institute (ABI), National Institutes of Biotechnology Malaysia (NIBM) in Malaysia.

We care about your privacy

We use cookies to improve user experience. We analyse our traffic, we personalise content and ads on our website, and we provide social media features. Certain cookies are necessary for our website to work properly and to enable you to use its features. With your consent, we also use analytics cookies to improve our website and marketing cookies to display advertisements and content on our website. 
Cookie settings